These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8962201)

  • 1. Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: preliminary results.
    Terenzi A; Aristei C; Aversa F; Perruccio K; Chionne F; Raymondi C; Latini P; Martelli MF
    Transplant Proc; 1996 Dec; 28(6):3101. PubMed ID: 8962201
    [No Abstract]   [Full Text] [Related]  

  • 2. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
    Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH
    Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of T cell-depleted bone marrow allografts in mice by thiotepa.
    Terenzi A; Lubin I; Lapidot T; Salomon O; Faktorowich Y; Rabi I; Martelli MF; Reisner Y
    Transplantation; 1990 Oct; 50(4):717-20. PubMed ID: 2120811
    [No Abstract]   [Full Text] [Related]  

  • 7. Graft engineering using ex vivo methods to limit GVHD: fludarabine treatment generates superior GVL effects in allogeneic BMT.
    Li JM; Giver CR; Waller EK
    Exp Hematol; 2006 Jul; 34(7):895-904. PubMed ID: 16797417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An allogeneic immunosuppressive monoclonal anti-T cell antibody can elicit neutralizing anti-antibodies in mice.
    Kremmer E; Mysliwietz J; Lederer R; Thierfelder S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):842-3. PubMed ID: 8094918
    [No Abstract]   [Full Text] [Related]  

  • 9. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
    Kang HJ; Shin HY; Choi HS; Ahn HS
    Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
    Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
    Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin effects on immunologic reconstitution.
    Vogelsang GB; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):727-8. PubMed ID: 8438459
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloablative and immunosuppressive properties of treosulfan in mice.
    Sjöö F; Hassan Z; Abedi-Valugerdi M; Griskevicius L; Nilsson C; Remberger M; Aschan J; Concha H; Gaughan U; Hassan M
    Exp Hematol; 2006 Jan; 34(1):115-21. PubMed ID: 16413398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymectomy and severe combined immune-deficient bone marrow transplantation eradicates natural antibody of mice to human blood cells.
    Huppes W; Dijk J; Kinwel-Bohre EP; Van Bekkum DW
    Transplantation; 1993 Dec; 56(6):1568-9. PubMed ID: 8305084
    [No Abstract]   [Full Text] [Related]  

  • 16. LF 08-0299 protects murine recipients of minor antigen disparate donor bone marrow from lethal graft-versus-host disease.
    Bruley-Rosset M; Churaqui E; Annat J; Dutartre P
    Transplant Proc; 1996 Dec; 28(6):3114-6. PubMed ID: 8962208
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation.
    Terenzi A; Aristei C; Aversa F; Pasqualucci L; Albi N; Velardi A; Latini P; Martelli MF
    Transplant Proc; 1994 Dec; 26(6):3217. PubMed ID: 7998120
    [No Abstract]   [Full Text] [Related]  

  • 18. [Second nonmyeloablative allogeneic peripheral blood stem cell transplantation with more immunosuppressive conditioning regimen for the late graft failure of the patient with acute myeloid leukemia].
    Tachikawa Y; Abe Y; Choi I; Ohtsuka R; Nagasawa E; Shibata K; Nishimura J; Nawata H; Muta K
    Fukuoka Igaku Zasshi; 2005 Nov; 96(11):378-82. PubMed ID: 16502857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rapamycin after syngeneic bone marrow transplantation in irradiated mice.
    Quesniaux V; Gibbons H; Maurer C; Stirnimann R; Wehrli S
    Transplant Proc; 1996 Dec; 28(6):3065-71. PubMed ID: 8962188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.